Prof. François Mach (h index >50), born in 1961, is an expert in the field of cardiology, in particular with regard to the development and progression of atherosclerosis diseases. After obtaining his MD at the University of Geneva, Switzerland, he studied internal medicine and cardiology at Geneva University Hospital. He then went on to complete a post-doctoral fellowship in the laboratory of Prof. Peter Libby, Brigham and Women’s Hospital, Boston (1995-1999). Following his return to Switzerland in 2000, he became full Professor of cardiology, and in 2006 he was appointed Head of the cardiology department at Geneva University Hospital. Between 2012-14, he was the President of the Swiss Society of Cardiology. François Mach is the author of more than 400 high impact factor publications, has obtained several European research grants (“European Vascular Genomic Network” [EVGN] FP6, “Inflammation and Vascular Wall Remodelling in Atherosclerosis” [AtheroRemo] FP7), and is currently involved
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease